BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10329443)

  • 21. Angiostatin induces mitotic cell death of proliferating endothelial cells.
    Hari D; Beckett MA; Sukhatme VP; Dhanabal M; Nodzenski E; Lu H; Mauceri HJ; Kufe DW; Weichselbaum RR
    Mol Cell Biol Res Commun; 2000 May; 3(5):277-82. PubMed ID: 10964751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kringle 5 peptide-albumin conjugates with anti-migratory activity.
    Léger R; Benquet C; Huang X; Quraishi O; van Wyk P; Bridon D
    Bioorg Med Chem Lett; 2004 Feb; 14(4):841-5. PubMed ID: 15012978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning, expression, and in vitro activity of human endostatin.
    Dhanabal M; Volk R; Ramchandran R; Simons M; Sukhatme VP
    Biochem Biophys Res Commun; 1999 May; 258(2):345-52. PubMed ID: 10329390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of tumor growth with recombinant murine angiostatin.
    Wu Z; O'Reilly MS; Folkman J; Shing Y
    Biochem Biophys Res Commun; 1997 Jul; 236(3):651-4. PubMed ID: 9245707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial progenitor cells as putative targets for angiostatin.
    Ito H; Rovira II; Bloom ML; Takeda K; Ferrans VJ; Quyyumi AA; Finkel T
    Cancer Res; 1999 Dec; 59(23):5875-7. PubMed ID: 10606226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation.
    Troyanovsky B; Levchenko T; Månsson G; Matvijenko O; Holmgren L
    J Cell Biol; 2001 Mar; 152(6):1247-54. PubMed ID: 11257124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysyl 4-aminobenzoic acid derivatives as potent small molecule mimetics of plasminogen kringle 5.
    Sheppard GS; Kawai M; Craig RA; Davidson DJ; Majest SM; Bell RL; Henkin J
    Bioorg Med Chem Lett; 2004 Feb; 14(4):965-6. PubMed ID: 15013002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
    Kuba K; Matsumoto K; Ohnishi K; Shiratsuchi T; Tanaka M; Nakamura T
    Biochem Biophys Res Commun; 2000 Dec; 279(3):846-52. PubMed ID: 11162438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
    Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity.
    Lee H; Kim HK; Lee JH; You WK; Chung SI; Chang SI; Park MH; Hong YK; Joe YA
    Arch Biochem Biophys; 2000 Mar; 375(2):359-63. PubMed ID: 10700393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator.
    Kim HK; Lee SY; Oh HK; Kang BH; Ku HJ; Lee Y; Shin JY; Hong YK; Joe YA
    Biochem Biophys Res Commun; 2003 May; 304(4):740-6. PubMed ID: 12727218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
    Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
    Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer.
    Matsuda KM; Madoiwa S; Hasumi Y; Kanazawa T; Saga Y; Kume A; Mano H; Ozawa K; Matsuda M
    Cancer Gene Ther; 2000 Apr; 7(4):589-96. PubMed ID: 10811477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen.
    Heidtmann HH; Nettelbeck DM; Mingels A; Jäger R; Welker HG; Kontermann RE
    Br J Cancer; 1999 Dec; 81(8):1269-73. PubMed ID: 10604721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of kringle 5 domain of human plasminogen in Pichia pastoris.
    Zhu M; Cheng J; Hua ZC
    Prep Biochem Biotechnol; 2003 Nov; 33(4):269-81. PubMed ID: 14606685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis.
    Veitonmäki N; Cao R; Wu LH; Moser TL; Li B; Pizzo SV; Zhivotovsky B; Cao Y
    Cancer Res; 2004 May; 64(10):3679-86. PubMed ID: 15150128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.
    Stack MS; Gately S; Bafetti LM; Enghild JJ; Soff GA
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):77-84. PubMed ID: 10229661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.
    Su L; Xu X; Zhao H; Gu Q; Zou H
    Biochem Biophys Res Commun; 2010 Jun; 396(4):1012-7. PubMed ID: 20471363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple forms of angiostatin induce apoptosis in endothelial cells.
    Lucas R; Holmgren L; Garcia I; Jimenez B; Mandriota SJ; Borlat F; Sim BK; Wu Z; Grau GE; Shing Y; Soff GA; Bouck N; Pepper MS
    Blood; 1998 Dec; 92(12):4730-41. PubMed ID: 9845539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
    Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
    J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.